INNOCAN PHARMA Corp (INNPF)
INNOCAN PHARMA Corp operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Calgary, AB, CA. The stock last traded at $1.62, down 7.43% on the session, giving a market capitalisation of $7.3M. On trailing twelve-month figures it carries a trailing P/E of -7.49, a net margin of -4.0%. Its beta of -0.22 implies it has historically moved less than the broad market.
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.
INNOCAN PHARMA Corp is most often compared with the following Healthcare names: